Paradigm Biocapital Advisors LP - Aug 21, 2025 SCHEDULE 13G Report for Agios Pharmaceuticals, Inc. Common Stock, $0.001 par value per share (AGIO)

Filing Manager: Paradigm Biocapital Advisors LP
Reporting Manager: Paradigm BioCapital Advisors LP
Security: Agios Pharmaceuticals, Inc. Common Stock, $0.001 par value per share
Symbol: AGIO
Shares outstanding: 58.2M shares
Disclosed Ownership: 3.03M shares
Ownership: 5.2%
Form type: SCHEDULE 13G
Date filed: 8/28/2025, 04:31 PM
Date of event: Aug 21, 2025
Next filing: Nov 14, 2025
SEC: View on sec.gov

Reporting Managers (4)

Name	Ownership	Shares Owned	sole voting power	Signature	Title
Paradigm BioCapital Advisors LP	5.2%	3.03M	3.03M	/s/ David K. Kim	David K. Kim / Authorized Signatory
Paradigm BioCapital Advisors GP LLC	5.2%	3.03M	3.03M	/s/ David K. Kim	David K. Kim / Authorized Signatory
Senai Asefaw, M.D.	5.2%	3.03M	3.03M	/s/ Senai Asefaw, M.D.	N/A
Paradigm BioCapital International Fund Ltd.	4.6%	2.67M	2.67M	David K. Kim / Authorized Signatory	N/A